Suppr超能文献

急性心力衰竭的肾功能轨迹和临床结局。

Renal function trajectories and clinical outcomes in acute heart failure.

机构信息

Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

出版信息

Circ Heart Fail. 2014 Jan;7(1):59-67. doi: 10.1161/CIRCHEARTFAILURE.113.000556. Epub 2013 Nov 26.

Abstract

BACKGROUND

Prior studies have demonstrated adverse risk associated with baseline and worsening renal function in acute heart failure, but none has modeled the trajectories of change in renal function and their impact on outcomes.

METHODS AND RESULTS

We used linear mixed models of serial measurements of blood urea nitrogen and creatinine to describe trajectories of renal function in 1962 patients with acute heart failure and renal dysfunction enrolled in the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function study. We assessed risk of 180-day mortality and 60-day cardiovascular or renal readmission and used Cox regression to determine association between renal trajectories and outcomes. Compared with patients alive at 180 days, patients who died were older, had lower blood pressure and ejection fraction, and higher creatinine levels at baseline. On average for the entire cohort, creatinine rose from days 1 to 3 and increased further after discharge, with the trajectory dependent on the day of discharge. Blood urea nitrogen, creatinine, and the rate of change in creatinine from baseline were the strongest independent predictors of 180-day mortality and 60-day readmission, whereas the rate of change of blood urea nitrogen from baseline was not predictive of outcomes. Baseline blood urea nitrogen>35 mg/dL and increase in creatinine>0.1 mg/dL per day increased the risk of mortality, whereas stable or decreasing creatinine was associated with reduced risk.

CONCLUSIONS

Patients with acute heart failure and renal dysfunction demonstrate variable rise and fall in renal indices during and immediately after hospitalization. Risk of morbidity and mortality can be predicted based on baseline renal function and creatinine trajectory during the first 7 days.

CLINICAL TRIAL REGISTRATION

URL: http://www.clinicaltrials.gov. Unique identifiers: NCT00328692 and NCT00354458.

摘要

背景

先前的研究表明,急性心力衰竭患者的基线和肾功能恶化与不良风险相关,但没有研究肾功能变化的轨迹及其对预后的影响。

方法和结果

我们使用线性混合模型对 1962 例急性心力衰竭伴肾功能障碍患者的血尿素氮和肌酐的连续测量值进行建模,以描述 Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function 研究中肾功能的变化轨迹。我们评估了 180 天死亡率和 60 天心血管或肾脏再入院的风险,并使用 Cox 回归来确定肾功能变化轨迹与预后之间的关联。与 180 天存活的患者相比,死亡患者年龄更大,血压和射血分数更低,基线时肌酐水平更高。在整个队列中,肌酐从第 1 天到第 3 天升高,出院后进一步升高,其轨迹取决于出院日。血尿素氮、肌酐和从基线到肌酐的变化率是 180 天死亡率和 60 天再入院的最强独立预测因子,而血尿素氮从基线的变化率对结果没有预测能力。基线血尿素氮>35mg/dL 和肌酐每天增加>0.1mg/dL 增加了死亡率的风险,而稳定或降低的肌酐与降低的风险相关。

结论

急性心力衰竭伴肾功能障碍患者在住院期间和出院后,其肾功能指标呈现出不同的上升和下降趋势。根据第 1 天至第 7 天的基线肾功能和肌酐轨迹,可以预测发病率和死亡率的风险。

临床试验注册

网址:http://www.clinicaltrials.gov。唯一标识符:NCT00328692 和 NCT00354458。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验